US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist

1.3950
+0.0280+2.05%

Close Feb 28 16:00 ET

1.4100
+0.0150+1.08%

Post 19:59 ET

48.24MMarket Cap-1.11P/E (TTM)

Iterum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iterum Therapeutics Q4 2024 Earnings Date

Currency：USDFeb 7, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
EPS	-0.17	-0.25	-0.08
Miss Est.	+81.92%	+71.15%	-47.15%
Net Income	--	-6.58M	--
		+46.76%

Analyst Rating

No Data

Iterum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 2.800M	--
--	2025/Q1	-- / 2.683M	--
Feb 7, 2025	2024/Q4	0.000 / 0.000	--
Nov 14, 2024	2024/Q3	0.000 / 0.000	--
Aug 14, 2024	2024/Q2	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 2.800M--

--2025/Q1-- / 2.683M--

Feb 7, 20252024/Q40.000 / 0.000--

Nov 14, 20242024/Q30.000 / 0.000--

Aug 14, 20242024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Iterum Therapeutics Earnings Reports

Iterum Therapeutics | 10-K: FY2024 Annual Report

Feb 7 07:35 ET

Iterum Therapeutics | 8-K: Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 7 07:20 ET

Iterum Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14, 2024 07:36 ET

Iterum Therapeutics | 8-K: Iterum Therapeutics Reports Third Quarter 2024 Financial Results

Nov 14, 2024 07:16 ET